Melatonin and Epilepsy

Area of Science:

• Neurology
• Neuroendocrinology
• Biochemistry

Background:

• Epilepsy is a chronic neurological disorder characterized by recurrent seizures, posing significant medical and social challenges.
• Pathogenesis involves neuronal hyperactivity, often linked to oxidative stress, excitotoxicity, and mitochondrial dysfunction.
• Melatonin, a pineal gland neurohormone, regulates circadian rhythms and possesses antioxidant and cytoprotective properties.

Purpose of the Study:

• To investigate the potential role of melatonin in epilepsy management.
• To review existing research on the correlation between melatonin and epileptogenesis.
• To explore melatonin as an adjunct therapy for epilepsy.

Main Methods:

• Review of animal model studies on melatonin and epileptogenesis.
• Analysis of human studies examining melatonin levels and epilepsy.
• Exploration of melatonin's physiological functions and antioxidant properties.

Main Results:

• Animal studies predominantly support melatonin's anticonvulsant effects.
• Human studies present diverse results, with some suggesting a correlation between melatonin levels and epilepsy course.
• Melatonin's antioxidant and cytoprotective actions may contribute to its potential therapeutic benefits.

Conclusions:

• Evidence from animal models suggests melatonin may possess anticonvulsant properties.
• Human studies require further investigation to confirm melatonin's efficacy in epilepsy.
• Melatonin is being explored as a potential complementary therapy for epilepsy.